tiprankstipranks
Advertisement
Advertisement
Fulcrum Therapeutics Highlights Q1 Results and Sickle Cell Progress
PremiumCompany AnnouncementsFulcrum Therapeutics Highlights Q1 Results and Sickle Cell Progress
1M ago
Fulcrum Therapeutics (FULC) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Fulcrum Therapeutics (FULC) Q1 Earnings Cheat Sheet
1M ago
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
Premium
The Fly
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
2M ago
Fulcrum Therapeutics price target lowered to $17 from $18 at Truist
PremiumThe FlyFulcrum Therapeutics price target lowered to $17 from $18 at Truist
3M ago
Fulcrum PIONEER data reinforce pociredir differentiated profile, Wainwright says
Premium
The Fly
Fulcrum PIONEER data reinforce pociredir differentiated profile, Wainwright says
3M ago
Fulcrum Therapeutics move lower ‘overdone,’ says Stifel
Premium
The Fly
Fulcrum Therapeutics move lower ‘overdone,’ says Stifel
3M ago
Pociredir’s Emerging Strength in Sickle Cell Disease Positions FULC for Upside Ahead of 1Q26 Data
PremiumRatingsPociredir’s Emerging Strength in Sickle Cell Disease Positions FULC for Upside Ahead of 1Q26 Data
3M ago
Fulcrum’s Pociredir Trial Completion Adds a New Catalyst to the Sickle Cell Investment Story
Premium
Company Announcements
Fulcrum’s Pociredir Trial Completion Adds a New Catalyst to the Sickle Cell Investment Story
4M ago
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
Premium
The Fly
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100